Search Results

There are 2405 results for: content related to: Efalizumab for severe refractory atopic eczema: retrospective study on 11 cases

  1. An Overview of the Pharmacokinetics and Pharmacodynamics of Efalizumab: A Monoclonal Antibody Approved for Use in Psoriasis

    The Journal of Clinical Pharmacology

    Volume 46, Issue 1, January 2006, Pages: 10–20, Dr Amita Joshi, Dr Robert Bauer, Dr Peter Kuebler, Mr Mark White, Ms Cecelia Leddy, Mr Peter Compton, Dr Marvin Garovoy, Dr Paul Kwon, Dr Patricia Walicke and Dr Russell Dedrick

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270005283282

  2. Pharmacokinetics and Pharmacodynamics of Multiple Weekly Subcutaneous Efalizumab Doses in Patients With Plaque Psoriasis

    The Journal of Clinical Pharmacology

    Volume 45, Issue 3, March 2005, Pages: 286–298, Ms Deborah L. Mortensen, Dr Patricia A. Walicke, Dr Xiaolin Wang, Dr Paul Kwon, Dr Peter Kuebler, Dr Alice B. Gottlieb, Dr James G. Krueger, Dr Craig Leonardi, Dr Bruce Miller and Dr Amita Joshi

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270004270260

  3. Transitioning patients from efalizumab to alternative psoriasis therapies: findings from an open-label, multicenter, Phase IIIb study

    International Journal of Dermatology

    Volume 46, Issue 6, June 2007, Pages: 637–648, Alan Menter, Tiffani K. Hamilton, Darryl P. Toth, Hoi M. Leung, Graham Wetherill, Brian Hennessey, Marvin Garovoy, Paul Kwon, David M. Pariser and (for the Efalizumab Study Group)

    Article first published online : 5 JUN 2007, DOI: 10.1111/j.1365-4632.2007.03158.x

  4. Sequential treatment with biologics: switching from efalizumab to etanercept in 35 patients with high-need psoriasis

    Journal of the European Academy of Dermatology and Venereology

    Volume 24, Issue 12, December 2010, Pages: 1413–1420, C Antoniou, C Dessinioti, T Vergou, AJ Stratigos, G Avgerinou, M Kostaki and A Katsambas

    Article first published online : 9 NOV 2010, DOI: 10.1111/j.1468-3083.2010.03661.x

  5. Safety of efalizumab in adults with chronic moderate to severe plaque psoriasis: A phase IIIb, randomized, controlled trial

    International Journal of Dermatology

    Volume 45, Issue 5, May 2006, Pages: 605–614, Kim A. Papp, Reni Bressinck, Scott Fretzin, Bernard Goffe, Steven Kempers, Kenneth B. Gordon, Ivor Caro, Patricia A. Walicke, Xiaolin Wang, Alan Menter and the Efalizumab Study Group

    Article first published online : 7 FEB 2006, DOI: 10.1111/j.1365-4632.2006.02777.x

  6. CLinical experience acquired with the efalizumab (Raptiva®) (CLEAR) trial in patients with moderate-to-severe plaque psoriasis: results from a phase III international randomized, placebo-controlled trial

    British Journal of Dermatology

    Volume 155, Issue 1, July 2006, Pages: 170–181, L. Dubertret, W. Sterry, J.D. Bos, S. Chimenti, S. Shumack, C.G. Larsen, N.H. Shear, K.A. Papp and CLEAR Multinational Study Group

    Article first published online : 26 MAY 2006, DOI: 10.1111/j.1365-2133.2006.07344.x

  7. Long-term treatment of plaque psoriasis with efalizumab: an Italian experience

    British Journal of Dermatology

    Volume 156, Issue s2, April 2007, Pages: 17–23, A. Costanzo, K. Peris, M. Talamonti, A. Di Cesare, M. Concetta Fargnoli, E. Botti and S. Chimenti

    Article first published online : 16 MAR 2007, DOI: 10.1111/j.1365-2133.2007.07765.x

  8. Efalizumab (Raptiva)

    Handbook of Therapeutic Antibodies

    Karlheinz Schmitt-Rau, Sigbert Jahn, Pages: 827–850, 2008

    Published Online : 1 FEB 2008, DOI: 10.1002/9783527619740.ch31

  9. Population Pharmacokinetics of Efalizumab (Humanized Monoclonal Anti-CD11a Antibody) Following Long-Term Subcutaneous Weekly Dosing in Psoriasis Subjects

    The Journal of Clinical Pharmacology

    Volume 45, Issue 4, April 2005, Pages: 468–476, Dr Yu-Nien Sun, Dr Jian-Feng Lu, Dr Amita Joshi, Mr Peter Compton, Dr Paul Kwon and Dr Rene A. Bruno

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270004272731

  10. Managing moderate-to-severe psoriasis with efalizumab: experience at a single Spanish institute

    British Journal of Dermatology

    Volume 156, Issue s2, April 2007, Pages: 24–29, C. Ferrándiz and J.M. Carrascosa

    Article first published online : 16 MAR 2007, DOI: 10.1111/j.1365-2133.2007.07766.x

  11. You have free access to this content
    Experience with a Novel Efalizumab-Based Immunosuppressive Regimen to Facilitate Single Donor Islet Cell Transplantation

    American Journal of Transplantation

    Volume 10, Issue 9, September 2010, Pages: 2082–2091, N. A. Turgeon, J. G. Avila, J. A. Cano, J. J. Hutchinson, I. R. Badell, A. J. Page, A. B. Adams, M. H. Sears, P. H. Bowen, A. D. Kirk, T. C. Pearson and C. P. Larsen

    Article first published online : 25 AUG 2010, DOI: 10.1111/j.1600-6143.2010.03212.x

  12. Efalizumab in routine use: a clinical experience

    British Journal of Dermatology

    Volume 156, Issue s2, April 2007, Pages: 1–6, N. Selenko-Gebauer, F. Karlhofer and G. Stingl

    Article first published online : 16 MAR 2007, DOI: 10.1111/j.1365-2133.2007.07762.x

  13. The Greek experience with efalizumab in psoriasis from a University Dermatologic Hospital

    British Journal of Dermatology

    Volume 156, Issue s2, April 2007, Pages: 12–16, C. Antoniou, I. Stefanaki, A. Stratigos, G. Avgerinou, P. Stavropoulos, I. Potouridou, D. Polidorou, A.E. Moustou, M. Kosmadaki and A.D. Katsambas

    Article first published online : 16 MAR 2007, DOI: 10.1111/j.1365-2133.2007.07764.x

  14. Efalizumab in the treatment of chronic plaque psoriasis: experiences from the largest psoriasis treatment centre in Denmark

    British Journal of Dermatology

    Volume 156, Issue s2, April 2007, Pages: 7–11, Knud Kragballe

    Article first published online : 16 MAR 2007, DOI: 10.1111/j.1365-2133.2007.07763.x

  15. Efalizumab

    Dermatologic Therapy

    Volume 20, Issue 4, July 2007, Pages: 265–269, Manju Chacko and Jeffrey M Weinberg

    Article first published online : 25 OCT 2007, DOI: 10.1111/j.1529-8019.2007.00139.x

  16. You have free access to this content
    Onset of psoriatic arthritis in patients treated with efalizumab for moderate to severe psoriasis

    Arthritis & Rheumatism

    Volume 58, Issue 6, June 2008, Pages: 1796–1802, Manuelle Viguier, Pascal Richette, François Aubin, Marie Beylot-Barry, Morad Lahfa, Christophe Bedane, Franck Delesalle, Marie-Aleth Richard-Lallemand, Emmanuel Delaporte, Louis Dubertret, Thomas Bardin and Hervé Bachelez

    Article first published online : 31 MAY 2008, DOI: 10.1002/art.23507

  17. The application of mechanism-based PK/PD modeling in pharmacodynamic-based dose selection of muM17, a surrogate monoclonal antibody for efalizumab

    Journal of Pharmaceutical Sciences

    Volume 95, Issue 6, June 2006, Pages: 1258–1268, Benjamin Wu, Amita Joshi, Song Ren and Chee Ng

    Article first published online : 24 APR 2006, DOI: 10.1002/jps.20475

  18. You have free access to this content
    A Phase I/II Randomized Open-Label Multicenter Trial of Efalizumab, a Humanized Anti-CD11a, Anti-LFA-1 in Renal Transplantation

    American Journal of Transplantation

    Volume 7, Issue 7, July 2007, Pages: 1770–1777, F. Vincenti, R. Mendez, M. Pescovitz, P. R. Rajagopalan, A. H. Wilkinson, K. Butt, D. Laskow, D. P. Slakey, M. I. Lorber, J. P. Garg and M. Garovoy

    Article first published online : 9 JUN 2007, DOI: 10.1111/j.1600-6143.2007.01845.x

  19. Efalizumab treatment of psoriasis vulgaris: a cohort study in outpatient clinical practice

    Clinical and Experimental Dermatology

    Volume 34, Issue 4, June 2009, Pages: 469–475, L. Puig, E. Roé, X. García-Navarro, F. Corella and A. Alomar

    Article first published online : 10 DEC 2008, DOI: 10.1111/j.1365-2230.2008.02993.x

  20. CLinical Experience Acquired with Raptiva® (CLEAR) trial in patients with moderate-to-severe plaque psoriasis: results from extended treatment in an international, Phase III, placebo-controlled trial

    JDDG: Journal der Deutschen Dermatologischen Gesellschaft

    Volume 4, Issue 11, November 2006, Pages: 947–956, Wolfram Sterry, Georg Stingl, Richard G.B. Langley, Hugh Zacharie, Morad Lahfa, Alberto Giannetti, Carlos Ferrándiz, Rodney Sinclair, Jean-Hilaire Saurat and the CLEAR Multinational Study Group

    Article first published online : 25 OCT 2006, DOI: 10.1111/j.1610-0387.2006.06111.x